Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.8 USD | -12.39% | -14.71% | -5.54% |
06-24 | Leerink Partners Upgrades Solid Biosciences to Outperform From Market Perform, Price Target is $12 | MT |
06-21 | Top Premarket Gainers | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.54% | 254M | |
+16.45% | 123B | |
+21.96% | 115B | |
+23.73% | 25.85B | |
-20.05% | 20.9B | |
-16.28% | 16.77B | |
-16.52% | 16.52B | |
-44.35% | 15.56B | |
+63.91% | 15.49B | |
+2.52% | 13.45B |
- Stock Market
- Equities
- SLDB Stock
- News Solid Biosciences Inc.
- Transcript : Solid Biosciences Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 01